Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics and Transaction Details
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity for April 23, 2025:
- Shares Purchased: 851,841 ordinary shares for cancellation.
- Highest Price Paid: 383.70 pence per share.
- Lowest Price Paid: 376.50 pence per share.
- Volume Weighted Average Price: 380.20 pence per share.
- Post-Transaction Share Capital: 9,025,300,120 ordinary shares of £0.01 each.
- Treasury Shares Held: 4,080,205.
- Voting Shares Outstanding: 9,021,219,915.
Material Changes
The primary material change is the reduction of the company's share count due to the cancellation of 851,841 shares. Consequently, the number of ordinary shares with voting rights has been updated to 9,021,219,915, a figure shareholders must use for determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, management commentary on operations, or discussion of risks and contingencies. It is a statutory disclosure of a specific share transaction. The text notes that a full breakdown of individual trades is available via the London Stock Exchange and the company's investor website.
Key Facts for Investor Verification
- Verify the updated voting share count of 9,021,219,915 for compliance with disclosure thresholds.
- Confirm the execution of the buyback programme announced on March 28, 2025.
- Review the detailed trade breakdown at the provided RNS link for specific transaction timing and pricing.
- Note that this filing does not contain operational or financial performance data for the period.